Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PTI

Proteostasis Therapeutics (PTI) Stock Price, News & Analysis

Proteostasis Therapeutics logo

About Proteostasis Therapeutics Stock (NASDAQ:PTI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.00
$22.42
52-Week Range
N/A
Volume
9,405 shs
Average Volume
1.04 million shs
Market Capitalization
$37.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Proteostasis Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

PTI Stock News Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
See More Headlines

PTI Stock Analysis - Frequently Asked Questions

Proteostasis Therapeutics, Inc. (NASDAQ:PTI) released its quarterly earnings results on Monday, November, 16th. The company reported ($0.16) earnings per share for the quarter, beating analysts' consensus estimates of ($0.17) by $0.01.

Proteostasis Therapeutics (PTI) raised $51 million in an initial public offering on Thursday, February 11th 2016. The company issued 3,900,000 shares at $12.00-$14.00 per share. Leerink Partners and RBC Capital Markets served as the underwriters for the IPO and Baird and H.C. Wainwright & Co. were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Proteostasis Therapeutics investors own include BHP Group (BHP), Idera Pharmaceuticals (IDRA), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Bristol Myers Squibb (BMY), Rite Aid (RAD) and

Company Calendar

Last Earnings
11/16/2020
Today
7/03/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PTI
Fax
N/A
Employees
44
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$59.13 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$5 million
Price / Cash Flow
N/A
Book Value
$1.22 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$37.57 million
Optionable
Not Optionable
Beta
1.16
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:PTI) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners